Today: 13 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Palantir (PLTR) stock slides 5.6% as insider sale notice surfaces — what to watch next week

Palantir (PLTR) stock slides 5.6% as insider sale notice surfaces — what to watch next week

Palantir shares fell 5.6% to $167.86 Friday, their first 2026 session, after an SEC filing showed officer Ryan D. Taylor plans to sell up to 12,000 shares under a 10b5-1 plan. The stock swung from an early high near $183 to a low around $166. Markets reopen Monday with U.S. jobs and inflation data due next week. Palantir’s next earnings report is expected in early February.
4 January 2026
·
Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference

Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference

Establishment Labs shares fell 5.5% to $68.84 Friday, underperforming a flat Nasdaq. The company recently submitted its Motiva implants to the FDA for breast reconstruction approval. Management will present at the J.P. Morgan Healthcare Conference on Jan. 14. Establishment Labs posted a 2024 net loss of about $85 million on $166 million in revenue.
4 January 2026
··
Via Transportation stock sinks to 52-week low territory after 6% Friday slide — what to watch next for NYSE:VIA

Via Transportation stock sinks to 52-week low territory after 6% Friday slide — what to watch next for NYSE:VIA

Via Transportation shares fell 6.3% Friday to $27.18, near their 52-week low and about 41% below the company’s $46 IPO price from September. The drop came as the S&P 500 rose and mobility peers Uber and Lyft gained. Investors await key U.S. jobs and inflation data next week. Via remains unprofitable and faces risks from public-sector spending and regulatory challenges.
4 January 2026
Wave Life Sciences (WVE) stock slides 6% — what traders are watching next

Wave Life Sciences (WVE) stock slides 6% — what traders are watching next

Wave Life Sciences shares fell 6.2% to $15.95 Friday, underperforming the flat Nasdaq Biotechnology Index. The company expects more Phase 1 obesity trial data in Q1 2026. A December SEC filing said Wave’s equity raise, including over-allotments, was expected to bring in about $402.5 million. Early data showed WVE-007 reduced visceral fat by 9.4% at three months in a 32-person cohort.
4 January 2026
·
Exzeo Group (XZO) stock drops 6% into weekend — what investors are watching next

Exzeo Group (XZO) stock drops 6% into weekend — what investors are watching next

Exzeo shares fell 6.1% to $22.76 Friday, with trading volume jumping to 424,000 shares from 240,000 the previous session. The stock touched a low of $22.19 and a high of $24.49 during the day. Exzeo’s next earnings report is due Feb. 25. HCI Group, which owns 81.5% of Exzeo, disclosed its CEO Paresh Patel adopted a plan to buy up to 100,000 shares if prices drop further.
4 January 2026
Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics shares fell 6.5% to $72.76 on Friday, marking a seventh straight daily loss and leaving the stock down 29% from its early December peak. About 854,000 shares traded as investors shifted focus to 2026 trial milestones and funding. CEO Nello Mainolfi sold 30,000 shares in a pre-arranged plan on Dec. 31. The company raised $602 million in a December stock offering at $86 per share.
4 January 2026
·
Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software shares fell 6.7% to $187.63 on Friday, closing below key moving averages after a quiet news period. The stock’s 14-day RSI neared 30, signaling oversold conditions, as investors awaited U.S. jobs data and Guidewire’s next earnings in March. About 806,660 shares traded in a session marked by light volume. Guidewire last reported Q1 revenue of $332.6 million and raised its fiscal-year outlook in December.
4 January 2026
·
BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL Holdings shares fell 7.3% to $50.56 Friday, marking one of their steepest single-day drops in weeks. Keefe, Bruyette & Woods raised its price target to $60 but maintained a “market perform” rating. The decline came as the S&P 500 rose 0.19% and the Nasdaq was flat. BILL’s next key events include a Jan. 16 finance leadership change and an earnings update expected in early February.
4 January 2026
··
1 … 307 308 309 310 311 … 584

Stock Market Today

  • Crypto trader loses nearly all $50 million in single DeFi transaction due to slippage
    March 12, 2026, 8:40 PM EDT. A cryptocurrency trader lost nearly $50 million on Thursday in one transaction due to extreme slippage, a common risk in decentralized finance (DeFi) where price shifts occur during large trades in low-liquidity pools. The user swapped about $50.4 million of aEthUSDT, an interest-bearing token representing Tether stablecoins on Aave protocol, for aEthAAVE governance tokens via CoW Protocol. Because of thin liquidity, the swap executed at more than 99% slippage, leaving 327 aEthAAVE worth only $36,000. Arbitrage traders and intermediaries quickly exploited the price difference. Aave founder Stani Kulechov said the user received multiple warnings and had to accept the risk before proceeding. Aave plans to return $600,000 in related fees to the user. The loss follows a recent $27 million liquidation related to Aave's token pricing.
Go toTop